
  
    
      
        Background_NNP
        Hemochromatosis_NNP is_VBZ common_JJ among_IN northwestern_NN European_JJ
        peoples_NNS and_CC their_PRP$ descendants_NNS ._. This_DT disorder_NN is_VBZ typically_RB
        associated_VBN with_IN homozygosity_NN for_IN the_DT C_NNP 282_CD Y_NNP mutation_NN of_IN the_DT 
        HFE_NNP gene_NN (_( exon_NN 2_CD ,_, nt_RB 845_CD G_NNP â†’_NN A_DT )_) on_IN Ch_NNP 6_CD p_NN
        [_NN 1_CD ]_NN ._. C_NNP 282_CD Y_NNP lies_VBZ within_IN an_DT ancestral_JJ haplotype_NN which_WDT
        includes_VBZ the_DT human_JJ leukocyte_NN antigen_NN (_( HLA_NNP )_) haplotype_NN
        A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD [_NN 2_CD 3_CD 4_CD 5_CD ]_NN ._. The_DT ancestral_JJ haplotype_NN is_VBZ the_DT
        predominant_NN hemochromatosis-associated_JJ haplotype_NN in_IN many_JJ
        northwestern_NN European_JJ countries_NNS ,_, including_VBG Ireland_NNP [_NN 6_CD ]_NN ,_,
        Brittany_NNP [_NN 2_CD ]_NN ,_, Denmark_NNP [_NN 7_CD 8_CD ]_NN ,_, Sweden_NNP [_NN 9_CD ]_NN ,_, and_CC
        Germany_NNP [_NN 10_CD 11_CD ]_NN ._. This_DT is_VBZ attributed_VBN to_TO the_DT origin_NN of_IN the_DT
        C_NNP 282_CD Y_NNP mutation_NN on_IN an_DT A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotype_NN in_IN northwestern_NN
        Europe_NNP and_CC its_PRP$ early_JJ dissemination_NN by_IN Vikings_NNPS [_NN 3_CD 12_CD ]_NN ._.
        Modification_NNP of_IN the_DT ancestral_JJ chromosome_NN by_IN recombination_NN
        and_CC admixture_NN as_IN a_DT result_NN of_IN geographic_JJ migration_NN explains_VBZ
        the_DT occurrence_NN of_IN chromosomes_NNS bearing_NN C_NNP 282_CD Y_NNP in_IN association_NN
        with_IN different_JJ HLA_NNP haplotypes_NNS [_NN 2_CD 4_CD 8_CD 13_CD 14_CD 15_CD 16_CD ]_NN ._. Thus_RB
        some_DT non-ancestral_JJ haplotypes_NNS also_RB occur_VBP with_IN significantly_RB
        increased_VBN frequencies_NNS in_IN hemochromatosis_NNS patients_NNS in_IN
        various_JJ countries_NNS in_IN Europe_NNP and_CC in_IN descendants_NNS of_IN Europeans_NNPS
        [_NN 5_CD 16_CD ]_NN ._.
        In_IN North_NNP America_NNP ,_, phenotype_NN frequencies_NNS of_IN HLA_NNP alleles_NNS
        in_IN persons_NNS with_IN hemochromatosis_NNS and_CC in_IN control_NN populations_NNS
        have_VBP been_VBN reported_VBN from_IN Canada_NNP ,_, Utah_NNP ,_, and_CC Minnesota_NNP [_NN 17_CD 18_CD
        19_CD ]_NN ._. HLA_NNP haplotype_NN frequencies_NNS for_IN hemochromatosis_NNS
        patients_NNS and_CC control_NN subjects_NNS in_IN North_NNP America_NNP have_VBP been_VBN
        reported_VBN only_RB from_IN Utah_NNP [_NN 20_CD ]_NN ._. The_DT purpose_NN of_IN the_DT present_JJ
        work_NN was_VBD to_TO quantify_VB and_CC analyze_VB the_DT frequencies_NNS of_IN HLA-A_NNP
        and_CC -_: B_NNP alleles_NNS and_CC haplotypes_NNS in_IN hemochromatosis_NNS probands_NNS
        with_IN C_NNP 282_CD Y_NNP homozygosity_NN in_IN central_JJ Alabama_NNP ,_, and_CC to_TO compare_VB
        the_DT present_JJ results_NNS to_TO those_DT reported_VBD in_IN other_JJ
        populations_NNS ._.
      
      
        Subjects_NNP and_CC Methods_NNP
        
          Selection_NN of_IN subjects_NNS
          
            Hemochromatosis_NNP probands_NNS
            The_DT performance_NN of_IN this_DT work_NN was_VBD approved_VBN by_IN the_DT
            Institutional_NNP Review_NNP Boards_NNP of_IN Brookwood_NNP Medical_NNP Center_NNP
            and_CC the_DT University_NNP of_IN Alabama_NNP at_IN Birmingham_NNP ._. A_DT
            presumptive_JJ diagnosis_NN of_IN hemochromatosis_NNS was_VBD
            established_VBN using_VBG an_DT elevated_VBD transferrin_NN saturation_NN
            criterion_NN ;_: each_DT proband_NN was_VBD subsequently_RB evaluated_VBN for_IN
            iron_NN overload_NN and_CC its_PRP$ complications_NNS [_NN 21_CD 22_CD 23_CD ]_NN ._. All_DT
            probands_NNS in_IN the_DT present_JJ study_NN were_VBD white_JJ adults_NNS (_( >_NN
            18_CD years_NNS of_IN age_NN )_) ._. Probands_NNP were_VBD included_VBN who_WP had_VBD :_: a_DT )_)
            diagnosis_NN of_IN hemochromatosis_NNS in_IN routine_JJ medical_JJ care_NN
            during_IN the_DT interval_NN 1997_CD -_: 2001_CD ;_: b_SYM )_) C_NNP 282_CD Y_NNP homozygosity_NN ;_:
            c_SYM )_) available_JJ HLA-A_NNP and_CC -_: B_NNP typing_VBG ;_: and_CC d_SYM )_) residence_NN in_IN
            central_JJ Alabama_NNP ._. No_DT patient_NN declined_VBD to_TO undergo_VB 
            HFE_NNP mutation_NN analysis_NN after_IN it_PRP
            was_VBD determined_VBN that_IN he_PRP /_NN she_PRP had_VBD a_DT hemochromatosis_NNS
            phenotype_NN ._. There_EX were_VBD A_DT and_CC B_NNP typing_VBG data_NNS in_IN 139_CD
            probands_NNS ._. Haplotypes_NNP could_MD not_RB be_VB determined_VBN in_IN 21_CD
            probands_NNS due_JJ to_TO similarities_NNS in_IN alleles_NNS of_IN probands_NNS and_CC
            family_NN members_NNS ,_, or_CC due_JJ to_TO unavailability_NN of_IN family_NN
            members_NNS for_IN analysis_NN ._. Thus_RB ,_, there_EX were_VBD haplotype_NN data_NNS
            on_IN 118_CD probands_NNS ._.
          
          
            Control_NN subjects_NNS
            Data_NNS from_IN 1_CD ,_, 321_CD apparently_RB normal_JJ ,_, unrelated_JJ white_JJ
            adult_NN subjects_NNS from_IN Alabama_NNP who_WP had_VBD undergone_VBN A_DT and_CC B_NNP
            phenotype_NN analysis_NN as_IN part_NN of_IN paternity_NN testing_NN were_VBD
            used_VBN to_TO estimate_VB allele_NN and_CC gene_NN frequencies_NNS [_NN [_NN 21_CD ]_NN ;_:
            R_NN ._. T_NN ._. Acton_NNP ,_, unpublished_JJ observations_NNS ]_NN ._. A_DT and_CC B_NNP
            haplotypes_NNS were_VBD determined_VBN in_IN 605_CD unrelated_JJ white_JJ
            subjects_NNS from_IN Alabama_NNP (_( children_NNS and_CC their_PRP$ mothers_NNS
            and_CC /_NN or_CC putative_JJ fathers_NNS )_) who_WP had_VBD undergone_VBN testing_NN to_TO
            establish_VB paternity_NN ._.
          
        
        
          Laboratory_NN methods_NNS
          Serum_NNP iron_NN concentration_NN ,_, transferrin_NN saturation_NN ,_, and_CC
          serum_NN ferritin_NN concentration_NN were_VBD measured_VBN using_VBG
          automated_VBN clinical_JJ methods_NNS ._. Sections_NNP of_IN liver_NN biopsy_NN
          specimens_NNS were_VBD stained_JJ using_VBG hematoxylin_NN and_CC eosin_NN ,_,
          Masson_NNP 's_POS trichrome_NN ,_, and_CC Perls_NNP '_POS Prussian_NNP blue_NN techniques_NNS ;_:
          intrahepatocytic_JJ iron_NN was_VBD graded_JJ according_VBG to_TO the_DT method_NN
          of_IN Scheuer_NNP et_CC al_NN ._. [_NN 24_CD ]_NN ._.
          
          HFE_NNP mutation_NN analysis_NN was_VBD performed_VBN
          as_RB previously_RB described_VBD [_NN 23_CD ]_NN ._. A_DT and_CC B_NNP alleles_NNS were_VBD
          detected_VBN using_VBG low-resolution_JJ DNA-based_NNP typing_VBG
          (_( PCR_NNP /_NN sequence-specific_JJ oligonucleotide_NN probe_NN )_) in_IN probands_NNS
          [_NN 23_CD ]_NN ._. Control_NNP subjects_NNS were_VBD tested_VBN using_VBG the_DT
          microdroplet_NN lymphocytotoxicity_NN test_NN [_NN 25_CD ]_NN ;_: subjects_NNS
          were_VBD evaluated_VBN using_VBG antisera_NN that_WDT detected_VBD allele_NN
          assignments_NNS described_VBD in_IN the_DT 9_CD thInternational_NN
          Histocompatibility_NNP Workshop_NNP [_NN 26_CD ]_NN ._. Because_IN the_DT levels_NNS
          of_IN resolution_NN of_IN the_DT DNA-based_NNP and_CC serological_JJ typing_VBG
          methods_NNS we_PRP used_VBD are_VBP similar_JJ ,_, alleles_NNS detected_VBN by_IN these_DT
          respective_JJ methods_NNS provide_VBP concordant_NN allele_NN assignments_NNS ,_,
          with_IN the_DT exception_NN of_IN B_NNP *_NN 70_CD and_CC B_NNP *_NN 71_CD that_WDT were_VBD not_RB
          detected_VBN by_IN serological_JJ methods_NNS ._. 
          HFE_NNP mutation_NN analysis_NN and_CC HLA_NNP
          typing_VBG of_IN family_NN members_NNS were_VBD performed_VBN to_TO permit_VB
          assignment_NN of_IN Ch_NNP 6_CD p_NN haplotypes_NNS ._. In_IN each_DT proband_NN in_IN whom_WP a_DT
          single_VB A_DT or_CC B_NNP allele_NN was_VBD detected_VBN by_IN DNA-based_NNP typing_VBG ,_, we_PRP
          verified_VBN the_DT allele_NN (_( s_VBZ )_) and_CC set_VBN phase_NN to_TO ascertain_VB
          haplotypes_NNS of_IN the_DT proband_NN using_VBG 
          HFE_NNP and_CC HLA_NNP analyses_NNS of_IN appropriate_JJ
          family_NN members_NNS ._. For_IN the_DT present_JJ analysis_NN ,_, all_DT haplotypes_NNS
          were_VBD defined_VBN only_RB by_IN A_DT and_CC B_NNP alleles_NNS ,_, and_CC the_DT ancestral_JJ
          haplotype_NN was_VBD defined_VBN as_IN a_DT hemochromatosis-associated_JJ
          Ch_NNP 6_CD p_NN bearing_VBG A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD and_CC 
          HFE_NNP C_NNP 282_CD Y_NNP ._.
        
        
          Literature_NNP review_NN
          For_IN most_JJS comparisons_NNS ,_, recent_JJ tabulations_NNS of_IN A_DT and_CC B_NNP
          allele_NN associations_NNS in_IN 21_CD case-control_JJ studies_NNS from_IN
          thirteen_NN countries_NNS and_CC A_DT and_CC B_NNP haplotype_NN analyses_NNS in_IN
          persons_NNS with_IN hemochromatosis_NNS and_CC control_NN subjects_NNS in_IN
          eight_CD countries_NNS or_CC regions_NNS were_VBD used_VBN [_NN 16_CD ]_NN ._. We_PRP also_RB
          made_VBD computerized_JJ and_CC manual_JJ searches_NNS to_TO identify_VB
          estimates_NNS of_IN the_DT prevalence_NN of_IN C_NNP 282_CD Y_NNP homozygosity_NN in_IN
          hemochromatosis_NNS cases_NNS in_IN various_JJ countries_NNS or_CC regions_NNS for_IN
          which_WDT A_DT and_CC B_NNP haplotype_NN data_NNS were_VBD also_RB available_JJ ._.
        
        
          Statistical_NNP considerations_NNS
          A_DT data_NNS set_VBN that_WDT included_VBD HLA_NNP types_NNS in_IN 139_CD probands_NNS and_CC
          haplotypes_NNS in_IN 118_CD probands_NNS was_VBD available_JJ ._. Absolute_JJ or_CC
          "_'' uncorrected_JJ "_'' values_NNS of_IN A_DT and_CC B_NNP phenotype_NN frequencies_NNS in_IN
          probands_NNS ,_, respective_JJ frequencies_NNS of_IN A_DT and_CC B_NNP genes_NNS ,_, A_DT and_CC
          B_NNP haplotype_NN frequencies_NNS ,_, and_CC occurrence_NN of_IN two-haplotype_JJ
          combinations_NNS were_VBD calculated_VBN after_IN enumeration_NN of_IN the_DT raw_JJ
          data_NN ._. Some_DT previously_RB reported_VBN hemochromatosis-associated_JJ
          HLA_NNP broad_JJ specificities_NNS are_VBP designated_VBN herein_NN as_IN
          corresponding_JJ splits_NNS (_( A_DT *_NN 09_CD =_SYM A_DT *_NN 23_CD and_CC A_DT *_NN 24_CD ;_: B_NNP *_NN 05_CD =_SYM B_NNP *_NN 51_CD
          and_CC B_NNP *_NN 52_CD ;_: and_CC B_NNP *_NN 12_CD =_SYM B_NNP *_NN 44_CD and_CC B_NNP *_NN 45_CD ,_, respectively_RB )_) [_NN 26_CD ]_NN
          ._. A_DT computer_NN spreadsheet_NN (_( Excel_NNP 2000_CD ,_, Microsoft_NNP Corp_NNP ._. ,_,
          Redmond_NNP ,_, WA_NNP )_) and_CC a_DT statistical_JJ program_NN (_( GB-Stat_NNP ,_, v_NN ._. 8_CD ._. 0_CD
          2000_CD ,_, Dynamic_NNP Microsystems_NNPS ,_, Inc_NNP ._. ,_, Silver_NNP Spring_NNP ,_, MD_NNP )_) were_VBD
          used_VBN to_TO perform_VB the_DT present_JJ analyses_NNS ._. Frequency_NNP values_NNS
          were_VBD compared_VBN using_VBG chi-square_JJ analysis_NN or_CC one-tail_JJ
          Fisher_NNP 's_POS exact_JJ test_NN ,_, as_IN appropriate_JJ ._. A_DT value_NN of_IN 
          p_NN <_NN 0_CD ._. 05_CD was_VBD defined_VBN as_IN
          significant_JJ ,_, and_CC these_DT values_NNS were_VBD expressed_VBN to_TO four_CD
          significant_JJ figures_NNS ._. Odds_NNS ratios_NNS (_( OR_NNP )_) were_VBD calculated_VBN as_RB
          previously_RB described_VBD [_NN 27_CD ]_NN ._. Bonferroni_NNP 's_POS correction_NN for_IN
          multiple_JJ tests_NNS was_VBD not_RB performed_VBN because_IN many_JJ of_IN the_DT HLA_NNP
          associations_NNS with_IN hemochromatosis_NNS reported_VBD herein_NN have_VBP
          been_VBN described_VBN elsewhere_RB ._.
        
      
      
        Results_NNS
        
          Hemochromatosis_NNP probands_NNS
          There_EX were_VBD 87_CD men_NNS ages_NNS 51_CD Â±_NN 4_CD years_NNS (_( mean_VB Â±_NN 1_CD S_NNP ._. D_NNP ._. )_)
          and_CC 52_CD women_NNS ages_NNS 50_CD Â±_NN 5_CD years_NNS ._. Iron_NNP overload_NN was_VBD
          detected_VBN using_VBG serum_NN ferritin_NN concentration_NN ,_, hepatic_JJ iron_NN
          index_NN ,_, or_CC quantitative_JJ phlebotomy_NN in_IN 135_CD probands_NNS ;_: three_CD
          women_NNS and_CC one_CD man_NN had_VBD no_DT evidence_NN of_IN iron_NN overload_NN ._.
          Twenty-six_NNP probands_NNS (_( 20_CD men_NNS ,_, 6_CD women_NNS )_) had_VBD hepatic_JJ
          cirrhosis_NNS demonstrated_VBN by_IN hepatic_JJ biopsy_NN ._. Eighteen_CD
          probands_NNS (_( 12_CD men_NNS ,_, 6_CD women_NNS )_) had_VBD diabetes_NN mellitus_JJ ._.
          Thirteen_CD men_NNS had_VBD hypogonadotrophic_JJ hypogonadism_NN ._.
          Cardiomyopathy_NNP attributable_JJ to_TO iron_VB overload_NN was_VBD not_RB
          diagnosed_VBN in_IN any_DT proband_NN ._.
        
        
          Phenotype_NNP frequencies_NNS of_IN HLA-A_NNP and_CC -_: B_NNP
          alleles_NNS
          Fourteen_CD A_DT alleles_NNS were_VBD detected_VBN in_IN 139_CD probands_NNS
          (_( Table_NNP 1_LS )_) ._. Sixteen_NNP A_DT alleles_NNS were_VBD detected_VBN in_IN control_NN
          subjects_NNS ._. The_DT most_RBS frequent_JJ A_DT alleles_NNS in_IN probands_NNS were_VBD
          A_DT *_NN 02_CD (_( 0_CD ._. 3021_CD )_) ,_, A_DT *_NN 03_CD (_( 0_CD ._. 7482_CD )_) ,_, and_CC A_DT *_NN 11_CD (_( 0_CD ._. 1007_CD )_) ._. The_DT
          frequency_NN of_IN A_DT *_NN 03_CD was_VBD greater_JJR in_IN probands_NNS than_IN in_IN control_NN
          subjects_NNS (_( 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP 7_CD ._. 9_CD )_) ._. A_DT *_NN 01_CD and_CC
          A_DT *_NN 02_CD occurred_VBD with_IN significantly_RB lower_JJR frequencies_NNS in_IN
          probands_NNS than_IN in_IN control_NN subjects_NNS (_( Table_NNP 1_LS )_) ._.
          Twenty-five_CD B_NNP alleles_NNS were_VBD detected_VBN in_IN 139_CD probands_NNS
          (_( Table_NNP 2_LS )_) [_NN Additional_JJ file_NN 1_CD ]_NN ._. Thirty-four_CD B_NNP alleles_NNS
          were_VBD detected_VBN in_IN control_NN subjects_NNS ._. The_DT most_RBS frequent_JJ B_NNP
          alleles_NNS in_IN probands_NNS were_VBD B_NNP *_NN 07_CD (_( 0_CD ._. 4748_CD )_) ,_, B_NNP *_NN 08_CD (_( 0_CD ._. 1655_CD )_) ,_,
          B_NNP *_NN 14_CD (_( 0_CD ._. 1942_CD )_) ,_, and_CC B_NNP *_NN 44_CD (_( 0_CD ._. 2590_CD )_) ._. The_DT frequencies_NNS of_IN
          B_NNP *_NN 07_CD ,_, B_NNP *_NN 14_CD ,_, and_CC B_NNP *_NN 56_CD were_VBD greater_JJR in_IN probands_NNS than_IN those_DT
          in_IN the_DT control_NN subjects_NNS (_( 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP =_SYM 2_CD ._. 6_CD ;_: 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP =_SYM 3_CD ._. 5_CD ;_: and_CC 
          p_NN =_SYM 0_CD ._. 0325_CD ,_, OR_NNP =_SYM 3_CD ._. 8_CD ,_,
          respectively_RB )_) ._. B_NN *_NN 08_CD and_CC B_NNP *_NN 35_CD occurred_VBD with_IN significantly_RB
          lower_JJR frequencies_NNS in_IN probands_NNS than_IN in_IN control_NN subjects_NNS
          (_( Table_NNP 2_LS )_) [_NN Additional_JJ file_NN 1_CD ]_NN ._. Because_IN arthropathy_NN is_VBZ
          common_JJ in_IN persons_NNS with_IN hemochromatosis_NNS [_NN 28_CD ]_NN ,_, we_PRP
          compared_VBD the_DT frequencies_NNS of_IN B_NNP *_NN 27_CD in_IN probands_NNS and_CC control_NN
          subjects_NNS ;_: the_DT difference_NN was_VBD not_RB significant_JJ (_( Table_NNP 2_LS )_) [_NN
          Additional_JJ file_NN 1_CD ]_NN ._.
          Additional_JJ File_NNP 1_CD
          
          Click_NNP here_RB for_IN file_NN
        
        
          Frequencies_NNP of_IN HLA-A_NNP and_CC -_: B_NNP alleles_NNS
          Gene_NNP frequencies_NNS corresponding_JJ to_TO A_DT *_NN 01_CD and_CC A_DT *_NN 02_CD were_VBD
          significantly_RB lower_JJR in_IN probands_NNS than_IN in_IN control_NN subjects_NNS
          (_( 
          p_NN =_SYM 0_CD ._. 0014_CD ,_, OR_NNP =_SYM 0_CD ._. 5_CD and_CC 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP =_SYM 0_CD ._. 5_CD ,_,
          respectively_RB )_) ._. A_DT *_NN 03_CD was_VBD significantly_RB more_RBR frequent_JJ in_IN
          probands_NNS than_IN in_IN control_NN subjects_NNS (_( 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP =_SYM 6_CD ._. 1_LS )_) ._. Some_DT
          probands_NNS were_VBD homozygous_JJ for_IN A_DT alleles_NNS by_IN DNA-based_NNP
          typing_VBG and_CC family_NN studies_NNS :_: A_DT *_NN 01_CD (_( n_NN =_SYM 2_LS )_) ,_, A_DT *_NN 02_CD (_( n_NN =_SYM 7_CD )_) ,_,
          A_DT *_NN 03_CD (_( n_NN =_SYM 29_CD )_) ,_, A_DT *_NN 11_CD (_( n_NN =_SYM 1_LS )_) ,_, A_DT *_NN 24_CD (_( n_NN =_SYM 1_LS )_) ,_, and_CC A_DT *_NN 24_CD (_( n_NN =_SYM
          1_LS )_) ._. The_DT B_NNP *_NN 07_CD and_CC B_NNP *_NN 14_CD gene_NN frequencies_NNS were_VBD significantly_RB
          greater_JJR in_IN probands_NNS than_IN in_IN control_NN subjects_NNS (_( 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP =_SYM 2_CD ._. 5_CD and_CC 
          p_NN <_NN 0_CD ._. 0001_CD ,_, OR_NNP =_SYM 3_CD ._. 2_CD ,_,
          respectively_RB )_) ._. In_IN addition_NN ,_, the_DT B_NNP *_NN 56_CD allele_NN was_VBD more_RBR
          frequent_JJ in_IN probands_NNS (_( 
          p_NN =_SYM 0_CD ._. 0330_CD ,_, OR_NNP =_SYM 3_CD ._. 8_CD )_) ._. The_DT B_NNP *_NN 35_CD
          allele_NN was_VBD significantly_RB less_RBR frequent_JJ in_IN probands_NNS than_IN
          in_IN control_NN subjects_NNS (_( 
          p_NN =_SYM 0_CD ._. 0159_CD ,_, OR_NNP =_SYM 0_CD ._. 4_LS )_) ._. Some_DT
          probands_NNS were_VBD homozygous_JJ for_IN B_NNP alleles_NNS by_IN DNA-based_NNP
          typing_VBG and_CC family_NN studies_NNS :_: B_NNP *_NN 07_CD (_( n_NN =_SYM 13_CD )_) ,_, B_NNP *_NN 08_CD (_( n_NN =_SYM 3_LS )_) ,_,
          B_NNP *_NN 37_CD (_( n_NN =_SYM 1_LS )_) ,_, B_NNP *_NN 44_CD (_( n_NN =_SYM 2_LS )_) ,_, and_CC B_NNP *_NN 51_CD (_( n_NN =_SYM 1_LS )_) ._.
        
        
          HLA-A_NNP and_CC -_: B_NNP haplotypes_NNS
          Seventy-two_NNP different_JJ haplotypes_NNS were_VBD detected_VBN in_IN 118_CD
          probands_NNS and_CC 133_CD haplotypes_NNS were_VBD detected_VBN in_IN control_NN
          subjects_NNS ._. Twenty-three_NNP haplotypes_NNS detected_VBD in_IN probands_NNS
          were_VBD not_RB observed_VBN in_IN control_NN subjects_NNS (_( Table_NNP 3_LS )_) [_NN
          Additional_JJ file_NN 2_CD ]_NN ._.
          Additional_JJ File_NNP 2_CD
          
          Click_NNP here_RB for_IN file_NN
          The_DT most_RBS frequent_JJ haplotypes_NNS in_IN probands_NNS were_VBD
          A_DT *_NN 01_CD -_: B_NNP *_NN 08_CD (_( frequency_NN 0_CD ._. 0720_CD )_) ;_: A_DT *_NN 02_CD -_: B_NNP *_NN 44_CD (_( 0_CD ._. 0508_CD )_) ;_:
          A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD (_( 0_CD ._. 2966_CD )_) ;_: and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 14_CD (_( 0_CD ._. 0847_CD )_) ._. A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD and_CC
          A_DT *_NN 03_CD -_: B_NNP *_NN 14_CD were_VBD significantly_RB more_RBR frequent_JJ in_IN probands_NNS
          than_IN in_IN control_NN subjects_NNS (_( 
          p_NN <_NN 0_CD ._. 0001_CD ,_, respectively_RB ;_: OR_NNP =_SYM
          12_CD ._. 3_LS and_CC 11_CD ._. 1_LS ,_, respectively_RB )_) (_( Table_NNP 3_LS )_) [_NN Additional_JJ file_NN
          2_CD ]_NN ._. Fifty-eight_NNP probands_NNS (_( 48_CD ._. 2_LS %_NN )_) inherited_VBD the_DT ancestral_JJ
          haplotype_NN defined_VBN as_IN A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD ,_, 
          HFE_NNP C_NNP 282_CD Y_NNP ;_: 46_CD were_VBD heterozygous_JJ and_CC
          12_CD were_VBD homozygous_JJ for_IN the_DT haplotype_NN ._.
          Other_JJ haplotypes_NNS were_VBD also_RB significantly_RB more_RBR frequent_JJ
          in_IN probands_NNS than_IN in_IN control_NN subjects_NNS :_: A_DT *_NN 01_CD -_: B_NNP *_NN 60_CD ,_,
          A_DT *_NN 02_CD -_: B_NNP *_NN 39_CD ,_, A_DT *_NN 02_CD -_: B_NNP *_NN 62_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 13_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 15_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 27_CD ,_,
          A_DT *_NN 03_CD -_: B_NNP *_NN 35_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 44_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 47_CD ,_, and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 57_CD (_( Table_NNP 3_LS )_)
          [_NN Additional_JJ file_NN 2_CD ]_NN ._. The_DT combined_VBN frequencies_NNS of_IN these_DT
          ten_CD haplotypes_NNS in_IN probands_NNS was_VBD 0_CD ._. 1441_CD and_CC in_IN control_NN
          subjects_NNS was_VBD 0_CD ._. 0033_CD (_( 
          p_NN <_NN 0_CD ._. 0001_CD )_) ._. The_DT frequencies_NNS of_IN
          haplotypes_NNS which_WDT included_VBD B_NNP *_NN 07_CD or_CC B_NNP *_NN 14_CD without_IN A_DT *_NN 03_CD were_VBD
          not_RB significantly_RB different_JJ in_IN probands_NNS and_CC control_NN
          subjects_NNS (_( Table_NNP 3_LS )_) [_NN Additional_JJ file_NN 2_CD ]_NN ._. Homozygosity_NNP for_IN
          these_DT haplotypes_NNS was_VBD observed_VBN in_IN some_DT probands_NNS :_: A_DT *_NN 01_CD -_: B_NNP *_NN 08_CD
          (_( n_NN =_SYM 1_LS )_) ;_: A_DT *_NN 02_CD -_: B_NNP *_NN 07_CD (_( n_NN =_SYM 1_LS )_) ;_: A_DT *_NN 02_CD -_: B_NNP *_NN 44_CD (_( n_NN =_SYM 1_LS )_) ;_: and_CC
          A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD (_( n_NN =_SYM 12_CD )_) ._.
          Forty-four_NNP of_IN 118_CD probands_NNS (_( 37_CD ._. 3_LS %_NN )_) were_VBD
          HLA-haploidentical_NNP with_IN at_IN least_JJS one_CD other_JJ proband_NN in_IN the_DT
          present_JJ study_NN ._. Thirty-four_CD of_IN the_DT 44_CD probands_NNS (_( 77_CD ._. 3_LS %_NN )_) had_VBD
          the_DT A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotype_NN (_( Table_NNP 4_LS )_) ._. Four_CD had_VBD the_DT
          haplotypes_NNS A_DT *_NN 02_CD -_: B_NNP *_NN 39_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 13_CD ,_, or_CC A_DT *_NN 03_CD -_: B_NNP *_NN 44_CD ._.
          Altogether_RB ,_, fourteen_CD different_JJ haplotypes_NNS defined_VBN by_IN A_DT
          and_CC B_NNP typing_VBG occurred_VBN in_IN these_DT 44_CD probands_NNS (_( Table_NNP 4_LS )_) ._.
        
        
          Comparison_NNP of_IN Alabama_NNP hemochromatosis_NNS probands_NNS with_IN
          persons_NNS with_IN hemochromatosis_NNS in_IN other_JJ locations_NNS
          
            HLA-A_NNP and_CC -_: B_NNP alleles_NNS
            We_PRP compared_VBD the_DT present_JJ results_NNS with_IN data_NNS in_IN a_DT
            previously_RB published_VBN tabulation_NN of_IN A_DT and_CC B_NNP allele_NN
            associations_NNS in_IN 21_CD case-control_JJ studies_NNS from_IN 13_CD
            countries_NNS or_CC regions_NNS in_IN Europe_NNP ,_, Australia_NNP ,_, and_CC North_NNP
            America_NNP [_NN 16_CD ]_NN ._. This_DT tabulation_NN yielded_VBD a_DT mean_NN A_DT *_NN 03_CD
            phenotype_NN frequency_NN of_IN 0_CD ._. 75_CD (_( range_NN 0_CD ._. 53_CD -_: 0_CD ._. 83_CD )_) in_IN
            hemochromatosis_NNS patients_NNS and_CC 0_CD ._. 25_CD (_( range_NN 0_CD ._. 19_CD -_: 0_CD ._. 31_CD )_)
            in_IN control_NN subjects_NNS [_NN 16_CD ]_NN ._. In_IN Alabama_NNP subjects_NNS ,_,
            therefore_RB ,_, the_DT A_DT *_NN 03_CD phenotype_NN frequencies_NNS in_IN probands_NNS
            (_( 0_CD ._. 7482_CD )_) and_CC control_NN subjects_NNS (_( 0_CD ._. 2739_CD )_) were_VBD similar_JJ to_TO
            the_DT corresponding_JJ mean_NN values_NNS previously_RB tabulated_JJ [_NN 16_CD
            ]_NN ._. However_RB ,_, the_DT OR_NNP for_IN hemochromatosis_NNS associated_VBN with_IN
            A_DT *_NN 03_CD in_IN Alabama_NNP probands_NNS (_( 7_CD ._. 9_CD )_) was_VBD somewhat_RB greater_JJR
            than_IN the_DT corresponding_JJ mean_NN value_NN of_IN aggregate_JJ data_NNS
            from_IN the_DT tabulation_NN (_( OR_NNP =_SYM 6_CD ._. 6_CD ;_: range_NN 3_CD ._. 8_CD -_: 15_CD ._. 1_LS ;_: 95_CD %_NN
            confidence_NN interval_NN 5_CD ._. 7_CD -_: 7_CD ._. 6_CD )_) [_NN 16_CD ]_NN ._.
          
          
            HLA-A_NNP and_CC -_: B_NNP haplotypes_NNS
            We_PRP compared_VBD the_DT present_JJ results_NNS with_IN data_NNS in_IN a_DT
            previously_RB published_VBN tabulation_NN of_IN A_DT and_CC B_NNP haplotypes_NNS
            which_WDT occurred_VBD with_IN significantly_RB greater_JJR frequency_NN in_IN
            hemochromatosis_NNS patients_NNS than_IN in_IN corresponding_JJ control_NN
            patients_NNS ;_: data_NNS were_VBD available_JJ from_IN Germany_NNP ,_, Denmark_NNP ,_,
            Sweden_NNP ,_, Brittany_NNP ,_, Portugal_NNP ,_, Italy_NNP ,_, Australia_NNP ,_, and_CC Utah_NNP
            (_( Table_NNP 5_LS )_) [_NN Additional_JJ file_NN 3_CD ]_NN [_NN 16_CD ]_NN [_NN 31_CD ]_NN ._.
            Frequencies_NNP of_IN the_DT A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotype_NN were_VBD increased_VBN
            in_IN all_DT hemochromatosis_NNS patient_NN groups_NNS ._. The_DT frequencies_NNS
            of_IN the_DT A_DT *_NN 03_CD -_: B_NNP *_NN 14_CD haplotype_NN were_VBD significantly_RB increased_VBN
            in_IN persons_NNS with_IN hemochromatosis_NNS in_IN Brittany_NNP ,_, Sweden_NNP ,_,
            Utah_NNP ,_, and_CC Alabama_NNP (_( Table_NNP 5_LS )_) [_NN Additional_JJ file_NN 3_CD ]_NN [_NN 31_CD ]_NN
            ._. A_DT significantly_RB increased_VBN absolute_JJ frequency_NN of_IN the_DT
            haplotype_NN A_DT *_NN 03_CD -_: B_NNP *_NN 35_CD occurred_VBD in_IN Alabama_NNP probands_NNS and_CC in_IN
            hemochromatosis_NNS patients_NNS in_IN Italy_NNP [_NN 29_CD ]_NN ._. A_DT
            significantly_RB increased_VBN frequency_NN of_IN the_DT haplotype_NN
            A_DT *_NN 03_CD -_: B_NNP *_NN 15_CD was_VBD observed_VBN in_IN the_DT present_JJ Alabama_NNP
            hemochromatosis_NNS probands_NNS ;_: a_DT relative_JJ increase_NN in_IN this_DT
            haplotype_NN was_VBD detected_VBN in_IN hemochromatosis_NNS cohorts_NNS in_IN
            Brittany_NNP and_CC Utah_NNP [_NN 2_CD 20_CD ]_NN ._. A_DT significantly_RB increased_VBN
            frequency_NN of_IN the_DT haplotype_NN A_DT *_NN 03_CD -_: B_NNP *_NN 44_CD was_VBD observed_VBN in_IN
            the_DT present_JJ Alabama_NNP hemochromatosis_NNS probands_NNS ,_, whereas_IN a_DT
            relative_JJ increase_NN in_IN this_DT haplotype_NN was_VBD reported_VBN in_IN
            hemochromatosis_NNS cohorts_NNS in_IN Sweden_NNP ,_, Brittany_NNP ,_, and_CC Utah_NNP
            only_RB after_IN "_'' correction_NN "_'' of_IN the_DT data_NNS for_IN the_DT
            preponderance_NN of_IN other_JJ haplotypes_NNS (_( Table_NNP 5_LS )_) [_NN
            Additional_JJ file_NN 3_CD ]_NN [_NN 31_CD ]_NN ._. The_DT increased_VBN frequencies_NNS
            of_IN the_DT A_DT *_NN 01_CD -_: B_NNP *_NN 60_CD ,_, A_DT *_NN 02_CD -_: B_NNP *_NN 39_CD ,_, A_DT *_NN 02_CD -_: B_NNP *_NN 62_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 13_CD ,_,
            A_DT *_NN 03_CD -_: B_NNP *_NN 27_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 47_CD ,_, and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 57_CD haplotypes_NNS observed_VBD
            in_IN Alabama_NNP probands_NNS in_IN the_DT present_JJ study_NN were_VBD not_RB
            reported_VBN in_IN persons_NNS with_IN hemochromatosis_NNS in_IN the_DT seven_CD
            other_JJ countries_NNS for_IN which_WDT data_NNS were_VBD available_JJ (_( Table_NNP 5_LS )_)
            [_NN Additional_JJ file_NN 3_CD ]_NN [_NN 31_CD ]_NN ._.
            Additional_JJ File_NNP 3_CD
            
            Click_NNP here_RB for_IN file_NN
          
        
      
      
        Discussion_NNP
        A_DT *_NN 03_CD positivity_NN was_VBD detected_VBN in_IN more_JJR than_IN 74_CD %_NN of_IN Alabama_NNP
        C_NNP 282_CD Y_NNP homozygous_JJ hemochromatosis_NNS probands_NNS in_IN the_DT present_JJ
        study_NN ._. Similarly_RB ,_, the_DT frequency_NN of_IN A_DT *_NN 03_CD positivity_NN was_VBD
        significantly_RB increased_VBN in_IN Alabama_NNP hemochromatosis_NNS probands_NNS
        diagnosed_VBN before_IN the_DT discovery_NN of_IN 
        HFE_NNP [_NN 21_CD ]_NN ._. These_DT observations_NNS are_VBP
        consistent_JJ with_IN and_CC extend_VB the_DT findings_NNS of_IN 21_CD previously_RB
        reported_VBD case-controlled_JJ studies_NNS from_IN thirteen_NN countries_NNS
        which_WDT demonstrate_VBP the_DT significantly_RB increased_VBN prevalence_NN of_IN
        A_DT *_NN 03_CD in_IN persons_NNS with_IN hemochromatosis_NNS [_NN 16_CD ]_NN ._. The_DT alleles_NNS
        B_NNP *_NN 07_CD and_CC B_NNP *_NN 14_CD were_VBD also_RB more_RBR common_JJ in_IN the_DT present_JJ Alabama_NNP
        probands_NNS and_CC in_IN Alabama_NNP probands_NNS diagnosed_VBN before_IN discovery_NN
        of_IN 
        HFE_NNP than_IN in_IN corresponding_JJ control_NN
        subjects_NNS [_NN 21_CD ]_NN ._. The_DT present_JJ analysis_NN demonstrates_VBZ that_IN
        this_DT is_VBZ attributable_JJ largely_RB to_TO the_DT association_NN of_IN B_NNP *_NN 07_CD and_CC
        B_NNP *_NN 14_CD with_IN A_DT *_NN 03_CD ,_, consistent_JJ with_IN observations_NNS in_IN persons_NNS
        with_IN hemochromatosis_NNS patients_NNS from_IN many_JJ locations_NNS ,_,
        including_VBG Ireland_NNP [_NN 6_CD ]_NN ,_, Brittany_NNP [_NN 2_CD 32_CD 33_CD 34_CD ]_NN ,_, Denmark_NNP
        [_NN 7_CD 8_CD ]_NN ,_, Sweden_NNP [_NN 9_CD 35_CD 36_CD ]_NN ,_, Germany_NNP [_NN 10_CD 11_CD 37_CD 38_CD ]_NN ,_,
        Portugal_NNP [_NN 30_CD 39_CD ]_NN ,_, Italy_NNP [_NN 2_CD 40_CD ]_NN ,_, and_CC Utah_NNP [_NN 20_CD ]_NN ._.
        The_DT frequency_NN of_IN the_DT ancestral_JJ haplotype_NN defined_VBN by_IN
        A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD in_IN the_DT present_JJ Alabama_NNP probands_NNS is_VBZ greater_JJR than_IN
        that_DT reported_VBD in_IN persons_NNS with_IN hemochromatosis_NNS reported_VBD from_IN
        most_JJS other_JJ areas_NNS ._. It_PRP is_VBZ possible_JJ that_IN our_PRP$ method_NN of_IN
        selection_NN of_IN subjects_NNS for_IN the_DT present_JJ study_NN could_MD partly_RB
        account_VB for_IN this_DT ._. We_PRP selected_VBD only_RB probands_NNS who_WP had_VBD a_DT
        hemochromatosis_NNS phenotype_NN and_CC C_NNP 282_CD Y_NNP homozygosity_NN ._. Across_IN
        other_JJ studies_NNS of_IN HLA_NNP haplotypes_NNS in_IN subjects_NNS with_IN
        hemochromatosis_NNS ,_, criteria_NNS for_IN definition_NN of_IN hemochromatosis_NNS
        phenotypes_NNS differed_VBD ._. Some_DT studies_NNS included_VBD probands_NNS ,_,
        whereas_IN others_NNS included_VBD probands_NNS and_CC all_DT family_NN members_NNS
        with_IN hemochromatosis_NNS ;_: some_DT required_JJ demonstration_NN of_IN
        segregation_NN with_IN HLA_NNP haplotypes_NNS ,_, and_CC others_NNS did_VBD not_RB [_NN 33_CD 34_CD
        35_CD 36_CD 37_CD 38_CD 39_CD 40_CD 41_CD 42_CD 43_CD ]_NN ._. None_NN used_VBD 
        HFE_NNP mutation_NN analysis_NN as_IN an_DT inclusion_NN
        criterion_NN as_IN we_PRP required_VBD in_IN the_DT present_JJ study_NN ._. In_IN several_JJ
        countries_NNS in_IN northwestern_NN Europe_NNP ,_, however_RB ,_, the_DT percentage_NN
        of_IN C_NNP 282_CD Y_NNP homozygotes_NNS in_IN hemochromatosis_NNS case_NN series_NN is_VBZ
        greater_JJR than_IN 90_CD %_NN [_NN 33_CD 34_CD 35_CD 37_CD 38_CD ]_NN ._. In_IN Queensland_NNP ,_, a_DT
        frequency_NN of_IN C_NNP 282_CD Y_NNP homozygosity_NN of_IN 100_CD %_NN was_VBD reported_VBN among_IN
        patients_NNS identified_VBN by_IN phenotype_NN criteria_NNS [_NN 42_CD ]_NN ._. Thus_RB ,_,
        the_DT selection_NN criterion_NN of_IN C_NNP 282_CD Y_NNP homozygosity_NN in_IN the_DT
        present_JJ study_NN nonetheless_RB resulted_VBD in_IN a_DT group_NN of_IN
        hemochromatosis_NNS probands_NNS the_DT 
        HFE_NNP genotypes_NNS of_IN which_WDT are_VBP similar_JJ to_TO
        those_DT of_IN hemochromatosis_NNS patients_NNS of_IN northwestern_NN European_JJ
        descent_NN in_IN other_JJ studies_NNS ._.
        The_DT absolute_JJ frequencies_NNS of_IN haplotypes_NNS A_DT *_NN 01_CD -_: B_NNP *_NN 60_CD ,_,
        A_DT *_NN 02_CD -_: B_NNP *_NN 39_CD ,_, A_DT *_NN 02_CD -_: B_NNP *_NN 62_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 13_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 15_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 27_CD ,_,
        A_DT *_NN 03_CD -_: B_NNP *_NN 35_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 44_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 47_CD ,_, and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 57_CD (_( in_IN addition_NN
        to_TO A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 14_CD haplotypes_NNS )_) were_VBD significantly_RB
        greater_JJR in_IN Alabama_NNP probands_NNS than_IN in_IN control_NN subjects_NNS ._. A_DT
        significantly_RB increased_VBN absolute_JJ frequency_NN of_IN the_DT haplotype_NN
        A_DT *_NN 03_CD -_: B_NNP *_NN 35_CD has_VBZ also_RB been_VBN reported_VBN in_IN hemochromatosis_NNS
        patients_NNS in_IN Italy_NNP [_NN 29_CD ]_NN ._. The_DT present_JJ observations_NNS
        regarding_VBG this_DT haplotype_NN may_MD be_VB attributable_JJ to_TO the_DT large_JJ
        subgroup_NN of_IN persons_NNS of_IN Italian_JJ and_CC Sicilian_NNP descent_NN in_IN
        central_JJ Alabama_NNP [_NN 44_CD ]_NN ._. A_DT significantly_RB increased_VBN
        frequency_NN of_IN the_DT haplotype_NN A_DT *_NN 03_CD -_: B_NNP *_NN 15_CD was_VBD observed_VBN in_IN the_DT
        present_JJ Alabama_NNP hemochromatosis_NNS probands_NNS ,_, whereas_IN a_DT
        relative_JJ increase_NN in_IN this_DT haplotype_NN was_VBD detected_VBN in_IN
        hemochromatosis_NNS cohorts_NNS in_IN Brittany_NNP and_CC Utah_NNP only_RB after_IN
        "_'' correction_NN "_'' of_IN the_DT data_NNS for_IN the_DT preponderance_NN of_IN other_JJ
        haplotypes_NNS [_NN 2_CD 20_CD ]_NN ._. Similarly_RB ,_, a_DT significantly_RB increased_VBN
        frequency_NN of_IN the_DT haplotype_NN A_DT *_NN 03_CD -_: B_NNP *_NN 44_CD was_VBD observed_VBN in_IN the_DT
        present_JJ Alabama_NNP hemochromatosis_NNS probands_NNS ,_, whereas_IN a_DT
        relative_JJ increase_NN in_IN this_DT haplotype_NN was_VBD detected_VBN in_IN
        hemochromatosis_NNS cohorts_NNS in_IN Sweden_NNP ,_, Brittany_NNP ,_, and_CC Utah_NNP after_IN
        "_'' correction_NN "_'' of_IN the_DT data_NNS for_IN the_DT preponderance_NN of_IN other_JJ
        haplotypes_NNS [_NN 2_CD 8_CD 19_CD ]_NN ._. The_DT absolute_JJ frequency_NN of_IN the_DT
        haplotype_NN A_DT *_NN 03_CD -_: B_NNP *_NN 47_CD was_VBD increased_VBN in_IN central_JJ Alabama_NNP
        hemochromatosis_NNS probands_NNS ,_, whereas_IN a_DT "_'' corrected_VBN "_'' frequency_NN
        of_IN A_DT *_NN 03_CD -_: B_NNP *_NN 47_CD was_VBD increased_VBN in_IN hemochromatosis_NNS patients_NNS from_IN
        Denmark_NNP [_NN 8_CD ]_NN ._. The_DT other_JJ aforementioned_JJ haplotypes_NNS (_( except_IN
        A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 14_CD )_) have_VBP not_RB been_VBN reported_VBN to_TO occur_VB
        with_IN increased_VBN frequency_NN in_IN any_DT hemochromatosis_NNS cohort_NN from_IN
        locations_NNS other_JJ than_IN Alabama_NNP ._. Thus_RB ,_, we_PRP observed_VBD a_DT greater_JJR
        number_NN of_IN haplotypes_NNS which_WDT were_VBD significantly_RB increased_VBN in_IN
        frequency_NN among_IN the_DT present_JJ Alabama_NNP hemochromatosis_NNS
        probands_NNS than_IN have_VBP been_VBN reported_VBN in_IN other_JJ hemochromatosis_NNS
        populations_NNS ,_, including_VBG a_DT cohort_NN in_IN Utah_NNP [_NN 16_CD ]_NN ._. This_DT could_MD
        be_VB attributed_VBN to_TO a_DT greater_JJR degree_NN of_IN genetic_JJ heterogeneity_NN
        among_IN whites_NNS in_IN Alabama_NNP ,_, consistent_JJ with_IN previous_JJ reports_NNS
        of_IN genetic_JJ characteristics_NNS of_IN persons_NNS with_IN hemochromatosis_NNS
        in_IN this_DT geographic_JJ area_NN [_NN 23_CD 45_CD ]_NN ._. Alternatively_RB ,_, we_PRP had_VBD
        greater_JJR power_NN to_TO achieve_VB statistical_JJ significance_NN in_IN the_DT
        present_JJ analyses_NNS than_IN did_VBD some_DT other_JJ studies_NNS ._. Nonetheless_RB ,_,
        the_DT percentage_NN of_IN the_DT present_JJ probands_NNS who_WP were_VBD
        HLA-haploidentical_NNP with_IN at_IN least_JJS one_CD other_JJ proband_NN
        indicates_VBZ that_IN the_DT haplotypes_NNS among_IN hemochromatosis_NNS
        patients_NNS in_IN central_JJ Alabama_NNP are_VBP more_RBR restricted_JJ than_IN those_DT
        in_IN the_DT general_JJ population_NN [_NN 46_CD 47_CD ]_NN ._.
        In_IN Alabama_NNP subjects_NNS with_IN hemochromatosis_NNS ,_, the_DT A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD
        haplotype_NN is_VBZ not_RB invariably_RB associated_VBN with_IN inheritance_NN of_IN
        C_NNP 282_CD Y_NNP ._. The_DT frequency_NN of_IN the_DT A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotype_NN was_VBD
        significantly_RB increased_VBN in_IN Alabama_NNP hemochromatosis_NNS probands_NNS
        without_IN C_NNP 282_CD Y_NNP [_NN 23_CD ]_NN ,_, some_DT of_IN whom_WP had_VBD the_DT common_JJ 
        HFE_NNP missense_NN mutation_NN H_NNP 63_CD D_NNP [_NN 23_CD ]_NN ._.
        A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotypes_NNS associated_VBN with_IN H_NNP 63_CD D_NNP have_VBP also_RB been_VBN
        described_VBN in_IN Alabama_NNP subjects_NNS with_IN primary_JJ antibody_NN
        deficiency_NN [_NN 48_CD ]_NN ._. Some_DT Alabama_NNP subjects_NNS with_IN
        hemochromatosis_NNS have_VBP an_DT A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotype_NN which_WDT includes_VBZ
        the_DT novel_NN 
        HFE_NNP missense_NN mutation_NN I_PRP 105_CD T_NN [_NN 48_CD ]_NN ._.
        Thus_RB ,_, a_DT variety_NN of_IN 
        HFE_NNP missense_NN mutations_NNS occur_VBP in_IN
        association_NN with_IN A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotypes_NNS in_IN white_JJ
        Alabamians_NNP ._.
      
      
        Conclusions_NNP
        A_DT *_NN 03_CD and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD frequencies_NNS are_VBP increased_VBN in_IN Alabama_NNP
        probands_NNS ,_, like_IN other_JJ hemochromatosis_NNS cohorts_NNS ._. Increased_VBN
        absolute_JJ frequencies_NNS of_IN the_DT haplotype_NN A_DT *_NN 03_CD -_: B_NNP *_NN 35_CD have_VBP been_VBN
        reported_VBN only_RB in_IN the_DT present_JJ Alabama_NNP probands_NNS and_CC in_IN
        hemochromatosis_NNS patients_NNS in_IN Italy_NNP ._. Increased_VBN absolute_JJ
        frequencies_NNS of_IN A_DT *_NN 01_CD -_: B_NNP *_NN 60_CD ,_, A_DT *_NN 02_CD -_: B_NNP *_NN 39_CD ,_, A_DT *_NN 02_CD -_: B_NNP *_NN 62_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 13_CD ,_,
        A_DT *_NN 03_CD -_: B_NNP *_NN 15_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 27_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 44_CD ,_, A_DT *_NN 03_CD -_: B_NNP *_NN 47_CD ,_, and_CC A_DT *_NN 03_CD -_: B_NNP *_NN 57_CD
        were_VBD detected_VBN in_IN the_DT present_JJ cohort_NN of_IN Alabama_NNP
        hemochromatosis_NNS probands_NNS ,_, but_CC these_DT haplotypes_NNS have_VBP not_RB
        been_VBN reported_VBN to_TO occur_VB with_IN increased_VBN absolute_JJ frequency_NN in_IN
        other_JJ hemochromatosis_NNS populations_NNS ._. Modification_NNP of_IN the_DT
        ancestral_JJ chromosome_NN by_IN recombination_NN and_CC admixture_NN as_IN a_DT
        result_NN of_IN geographic_JJ migration_NN could_MD explain_VB the_DT previously_RB
        undescribed_JJ occurrence_NN of_IN HLA_NNP haplotypes_NNS that_WDT occur_VBP in_IN
        association_NN with_IN C_NNP 282_CD Y_NNP ._. These_DT results_NNS could_MD also_RB be_VB
        explained_VBN by_IN the_DT greater_JJR degree_NN of_IN genetic_JJ heterogeneity_NN in_IN
        white_JJ Alabamians_NNP than_IN in_IN other_JJ populations_NNS ,_, and_CC by_IN the_DT
        larger_JJR numbers_NNS of_IN probands_NNS and_CC control_NN subjects_NNS and_CC greater_JJR
        statistical_JJ power_NN to_TO demonstrate_VB significant_JJ differences_NNS in_IN
        the_DT present_JJ study_NN than_IN in_IN some_DT similar_JJ previous_JJ studies_NNS ._. A_DT
        variety_NN of_IN 
        HFE_NNP missense_NN mutations_NNS occur_VBP in_IN
        association_NN with_IN A_DT *_NN 03_CD -_: B_NNP *_NN 07_CD haplotypes_NNS in_IN white_JJ
        Alabamians_NNP ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Authors_NNP '_'' contributions_NNS
        Author_NN 1_CD (_( JCB_NNP )_) conceived_VBD the_DT study_NN ,_, and_CC contributed_VBD
        hemochromatosis_NNS probands_NNS ,_, proband_NN characterization_NN ,_, and_CC
        proband_NN HLA_NNP typing_VBG ,_, tabulated_JJ hemochromatosis_NNS proband_NN HLA_NNP
        frequency_NN values_NNS ,_, performed_VBD statistical_JJ comparisons_NNS ,_, and_CC
        formulated_VBN the_DT manuscript_NN ._. Author_NN 2_CD (_( RTA_NNP )_) contributed_VBD
        control_NN subjects_NNS ,_, their_PRP$ characterization_NN ,_, and_CC control_NN HLA_NNP
        typing_VBG ,_, performed_VBD statistical_JJ comparisons_NNS ,_, and_CC edited_JJ the_DT
        manuscript_NN ._. Both_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ
        manuscript_NN ._.
      
    
  
